All In MedTech

Device Trial Radar · NCT04386278

OrthoPulse Gen 2 Initial Device Evaluation and Assessment of Clinical Effectiveness (CA)

RI.2 OrthoPulse Gen 2 Initial Device Evaluation and Assessment of Clinical

Last checked: Nov 20, 2026Latest source record: Nov 23, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

56

Actual

Start

Jan 8, 2020

Primary completion

Jun 24, 2020

Study completion Jun 24, 2020

Sponsor

Lead sponsor
Biolux Research Holdings, Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 13, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 19 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a prospective, interventional, non-randomized, control, split-mouth, open-label, single centre, private practice study aimed to evaluate the effect of tooth movement during orthodontic treatment using a removeable thermoplastic orthodontic appliance. Intrusion and extrusion will be conducted using bilaterally equivalent elastomeric forces of 50 grams. A comparison of the rate of bilateral orthodontic tooth movement will be conducted using six (6) varied photobiomodulation interventions on the maxillary (upper) and mandibular (lower) arches. The OrthoPulse Gen 2 and OrthoPulse (commercially approved) devices are being used in this clinical investigation. Each subject enrolled will go through intrusion and extrusion. All subjects will be allocated to an OrthoPulse split-mouth intervention by the investigator.

Conditions

  • Orthodontic Tooth Movement

Interventions

  • Intervention 1Device

    Side one: No treatment Side two: OrthoPulse Gen 2 (2RP) for one minute

  • Intervention 2Device

    Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RP) for one minute

  • Intervention 3Device

    Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RP) for 5 minutes

  • Intervention 4Device

    Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RCW) for five minutes

  • Intervention 5Device

    Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for one minute

  • Intervention 6Device

    Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for five minutes

  • Intervention 7Device

    Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for one minute

  • Intervention 8Device

    Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RBP) for five minutes

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The rate of orthodontic tooth movementTime frame: 36 days (±12 days) from T0 visit

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Dr. Peter Brawn

    Vancouver, B.C, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.